10x Genomics Tumbles 12% — When High Science Meets Low Growth
10x Genomics experienced a 12% stock price drop following ARK Invest's significant share sale, despite exceeding Q4 earnings expectations. The episode discusses stagnant revenue guidance and its implications for the company's growth narrative and market valuation.